Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -29.09 is 96% above its 5-year average of -783.52, near the high end of its 5-year range (-1785.33–-25.99).
48.47% above its 12-month average of -56.46.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -4.46.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 37 comparable quarters.
EARNINGS PER SHARE (EPS)
-29.09
EARNINGS PER SHARE (EPS) AVG TTM
-56.46
EARNINGS PER SHARE (EPS) AVG 3Y
-589.82
EARNINGS PER SHARE (EPS) AVG 5Y
-783.52
EARNINGS PER SHARE (EPS) AVG 10Y
-53267.40
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+48.47%
CURRENT VS 3Y AVG
+95.07%
CURRENT VS 5Y AVG
+96.29%
CURRENT VS 10Y AVG
+99.95%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Decoy Therapeutics Inc.
Market Cap
$888387.00
Earnings Per Share (EPS)
-29.09
TTM Avg
-56.46
3Y Avg
-589.82
5Y Avg
-783.52
Market Cap
$885939.00
Earnings Per Share (EPS)
-180.45
TTM Avg
-617.40
3Y Avg
-559.80
5Y Avg
-483.70
Market Cap
$878396.00
Earnings Per Share (EPS)
-1.86
TTM Avg
-3.74
3Y Avg
-18.16
5Y Avg
-24.28
Market Cap
$787624.00
Earnings Per Share (EPS)
-11.80
TTM Avg
-236.00
3Y Avg
-263.84
5Y Avg
-205.13
Market Cap
$1.02M
Earnings Per Share (EPS)
-8.02
TTM Avg
-25.27
3Y Avg
-9.38
5Y Avg
-7.51
Market Cap
$707297.00
Earnings Per Share (EPS)
-5669.00
TTM Avg
-313854.00
3Y Avg
-213259.50
5Y Avg
-170757.60
Market Cap
$1.11M
Earnings Per Share (EPS)
-89.20
TTM Avg
-39.24
3Y Avg
-1704.73
5Y Avg
-1696.36
Market Cap
$1.14M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.03
3Y Avg
0.05
5Y Avg
0.05
Market Cap
$1.17M
Earnings Per Share (EPS)
N/A
TTM Avg
-76.17
3Y Avg
-936.34
5Y Avg
-837.30
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | $888387.00 | -29.09 | -56.46 | -589.82 | -783.52 |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | -180.45 | -617.40 | -559.80 | -483.70 |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | -1.86 | -3.74 | -18.16 | -24.28 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $787624.00 | -11.80 | -236.00 | -263.84 | -205.13 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -8.02 | -25.27 | -9.38 | -7.51 |
| CDT Equity Inc. (CDT)vs › | $707297.00 | -5669.00 | -313854.00 | -213259.50 | -170757.60 |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | -89.20 | -39.24 | -1704.73 | -1696.36 |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | N/A | -0.03 | 0.05 | 0.05 |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | N/A | -76.17 | -936.34 | -837.30 |
| HCW Biologics Inc. (HCWB)vs › | $570131.00 | -54.17 | -34.20 | -18.78 | -13.04 |
Trailing EPS (TTM)
$-29.09
Forward EPS (Est.)
$-8.96
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -25.99 |
| 2024-12-31 | -86.92 |
| 2023-12-31 | -461.04 |
| 2022-12-31 | -1785.33 |
| 2021-12-31 | -926.01 |
| 2020-12-31 | -1415.85 |
| 2019-12-31 | -6366.21 |
| 2018-12-31 | -87374.00 |
| 2017-12-31 | -149250.00 |
| 2016-12-31 | -182250.00 |
| 2015-12-31 | -156000.00 |
| 2014-12-31 | -342750.00 |
